News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

NCHT improves PFS in locally advanced prostate cancer
06 May 2024
byStephen Padilla
Neoadjuvant chemohormonal therapy (NCHT) plus radical prostatectomy (RP) confers significant biochemical progression-free survival (bPFS) benefits relative to neoadjuvant hormonal therapy (NHT) plus RP on patients with high-risk, locally advanced prostate cancer, reports a study.
NCHT improves PFS in locally advanced prostate cancer
06 May 2024
MIRASOL PRO data boost mirvetuximab soravtansine potential in FRα-positive ovarian cancer
06 May 2024
byAudrey Abella
Patient-reported outcomes (PROs) from the phase III MIRASOL trial underpin the potential of the antibody drug conjugate mirvetuximab soravtansine (MIRV) to improve health-related quality of life (HRQoL) in women with folate receptor-alpha positive platinum-resistant ovarian cancer (FRα-positive PROC) as opposed to investigator’s choice of chemotherapy.







